Translated with AI
As part of a press tour organized for Tajik media representatives, journalists visited New Cicon Pharmaceutical Co., Ltd., one of the largest pharmaceutical companies in China's Xinjiang Uyghur Autonomous Region.
A journalist from the Avesta.tj news agency was among the participants in the trip, where he learned about the company's production facilities, its research and development activities, and its modern approaches to drug development.
During the visit, company representatives discussed the development of the region's pharmaceutical industry, the implementation of innovative technologies, and measures to ensure high product quality. Particular attention was paid to the combination of modern scientific developments with the rich heritage of traditional Chinese and Uyghur medicine.
New Cicon Pharmaceutical is one of the flagship companies in Xinjiang's pharmaceutical industry. The company boasts state-of-the-art production lines and research centers where it develops new drugs and refines existing technologies.
Press tour participants had the opportunity to learn about the production process, quality control procedures, and the company's future development prospects. Company representatives emphasized their interest in expanding international cooperation and exchanging experience with foreign partners.
A visit to New Cicon Pharmaceutical was a key part of the press tour, allowing journalists to gain insight into the achievements of the Chinese pharmaceutical industry and the innovative potential of Xinjiang enterprises.
